Location: New York, NY
CIK: 0001609251 · Show all filings
Period: Q2 2017 (← Previous) (Next →)
Filing Date: Aug 14, 2017
Total Value: $329M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | BIOVERATIV INC | 708,754 | $42.65M | 12.9% | $54.46 | — | COM | 97075E100 |
| ENTA | ENANTA PHARMACEUTICALS INC | 1,104,992 | $39.76M | 12.1% | $35.70 | -10.4% | COM | 29251M106 |
| GILD | GILEAD SCIENCES INC | 532,434 | $37.69M | 11.4% | $52.64 | -8.2% | COM | 375558103 |
| UTHR | UNITED THERAPEUTICS CORP | 272,996 | $35.42M | 10.8% | $134.51 | -7.3% | COM | 91307C102 |
| — | SUCAMPO PHARMACEUTICALS-CL A | 2,819,708 | $29.61M | 9.0% | $11.89 | — | COM | 864909106 |
| OM2 | ORTHOFIX INTERNATIONAL NV | 583,807 | $27.14M | 8.2% | $32.47 | — | COM | N6748L102 |
| — | RTI SURGICAL INC | 4,465,086 | $26.12M | 7.9% | $4.39 | — | COM | 74975N105 |
| MRK | MERCK & CO. INC. | 382,434 | $24.51M | 7.4% | $41.59 | +11.9% | COM | 58933Y105 |
| — | HALYARD HEALTH INC | 570,964 | $22.43M | 6.8% | $40.65 | — | COM | 40650V100 |
| — | INVACARE CORP | 1,121,066 | $14.8M | 4.5% | $13.92 | — | COM | 461203101 |
| — | AMGEN INC | 77,079 | $13.28M | 4.0% | $172.23 | — | COM | 90478E103 |
| CNMD | CONMED CORP | 226,497 | $11.54M | 3.5% | $38.10 | +19.4% | COM | 207410101 |
| — | AVIRAGEN THERAPEUTICS INC | 2,836,326 | $1.899M | 0.6% | $1.21 | — | COM | 053761102 |
| — | DIGIRAD CORP | 334,179 | $1.353M | 0.4% | $4.41 | — | COM | 253827109 |
| — | JUNIPER PHARMACEUTICALS INC | 243,128 | $1.228M | 0.4% | $9.19 | — | COM | 48203L107 |